BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3512075)

  • 1. Experimental immunotherapy with NK-like cells. A preliminary report.
    Morales A; Pang AS
    Cancer Immunol Immunother; 1986; 21(2):156-60. PubMed ID: 3512075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells.
    Ratliff TL; Shapiro A; Catalona WJ
    Clin Immunol Immunopathol; 1986 Oct; 41(1):108-15. PubMed ID: 3527506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tumor burden on the modulation of natural killer cell activity.
    Morales A; Pang AS
    J Urol; 1984 Jun; 131(6):1229-31. PubMed ID: 6726932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers.
    Morales A; Pang AS
    J Urol; 1986 Jan; 135(1):191-3. PubMed ID: 3941461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Anti-Tumor Activity Can Be Achieved by
    Esteso G; Aguiló N; Julián E; Ashiru O; Ho MM; Martín C; Valés-Gómez M
    Front Immunol; 2021; 12():622995. PubMed ID: 33708215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.
    Ayari C; Besançon M; Bergeron A; LaRue H; Bussières V; Fradet Y
    Cancer Immunol Immunother; 2016 Feb; 65(2):223-34. PubMed ID: 26759009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    Kawahara M; Hasegawa N; Takaku H
    PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S; Yano O; Tokunaga T
    Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.
    Yamamoto S; Yamamoto T; Iho S; Tokunaga T
    Springer Semin Immunopathol; 2000; 22(1-2):35-43. PubMed ID: 10944798
    [No Abstract]   [Full Text] [Related]  

  • 12. NK cells are essential for effective BCG immunotherapy.
    Brandau S; Riemensberger J; Jacobsen M; Kemp D; Zhao W; Zhao X; Jocham D; Ratliff TL; Böhle A
    Int J Cancer; 2001 Jun; 92(5):697-702. PubMed ID: 11340575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.
    Pang AS; Morales A
    J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG induced killer cell activity.
    Koga S; Kiyohara T; Taniguchi K; Nishikido M; Kubota S; Sakuragi T; Shindo K; Saitoh Y
    Urol Res; 1988; 16(5):351-5. PubMed ID: 3059655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of natural killer cells in adenovirus-mediated p53 gene therapy.
    Carroll JL; Nielsen LL; Pruett SB; Mathis JM
    Mol Cancer Ther; 2001 Nov; 1(1):49-60. PubMed ID: 12467238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
    Khoo NK; Chan FP; Saarloos MN; Lala PK
    Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.